UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025870
Receipt number R000029736
Scientific Title Clinical study for early diagnosis of cancer metastasis by exosomes in serum
Date of disclosure of the study information 2017/01/28
Last modified on 2022/01/31 14:45:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study for early diagnosis of cancer metastasis by exosomes in serum

Acronym

Early diagnosis of cancer metastasis by exosomes

Scientific Title

Clinical study for early diagnosis of cancer metastasis by exosomes in serum

Scientific Title:Acronym

Early diagnosis of cancer metastasis by exosomes

Region

Japan


Condition

Condition

sarcoma

Classification by specialty

Orthopedics

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate metastatic risk of cancer patient by analysis of exosomes in serum

Basic objectives2

Others

Basic objectives -Others

Analyze exosomes of cancer patient before starting treatment

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Diagnostic accuracy of metastasis

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

5 years-old <

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Diagnosed with malignancy
ECOG Performance Status 0to 3
5 years old or more
WBC over 2,000/mm3
Plt over 50,000/mm3
Hb over 8.0g/dl

Key exclusion criteria

severe heart disease, renal dyfunction, respiratory failure, caogulation disorder
double cancer
pregnant
Other medical, social, or psychological conditions that in the opinion of an investigator precludes the patient from appropriate consent

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Katsuhiro
Middle name
Last name Hayashi

Organization

Kanazawa Univ

Division name

Orthopaedic department

Zip code

920-8641

Address

Takaramachi 13-1, Kanazawa, Japan

TEL

0762652374

Email

khayashi830@gmail.com


Public contact

Name of contact person

1st name Katsuhiro
Middle name
Last name Hayashi

Organization

Kanazawa Univ

Division name

Orthopaedic department

Zip code

920-8641

Address

Takaramachi 13-1, Kanazawa, Japan

TEL

0762652374

Homepage URL


Email

khayashi830@gmail.com


Sponsor or person

Institute

Kanazawa Univ

Institute

Department

Personal name



Funding Source

Organization

self

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB Kanazawa Univ

Address

Takaramachi13-1, Kanazawa

Tel

0762652000

Email

rinri@adm.kanazawa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 01 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2015 Year 10 Month 21 Day

Date of IRB

2017 Year 10 Month 21 Day

Anticipated trial start date

2017 Year 10 Month 21 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Patients who are treated in Kanazawa Univ


Management information

Registered date

2017 Year 01 Month 27 Day

Last modified on

2022 Year 01 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029736


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name